[Retracted] The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome

Table 1

Comparison of myocardial level between the two groups ().

Grouping	N	Troponin I level (Ng/L)		Creatine kinase isoenzyme (U/L)		Hypersensitive C-reactive protein (mg/L)
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group	30	1.89 ± 0.33	1.35 ± 0.44	18.29 ± 5.33	15.69 ± 2.56	8.93 ± 1.42	7.84 ± 0.69
Research group	30	1.83 ± 0.31	1.02 ± 0.33	18.20 ± 5.31	13.45 ± 2.31	8.99 ± 1.65	6.33 ± 1.33
t value		0.725	3.286	0.065	3.558	0.150	5.519
value		>0.05	<0.05	>0.05	<0.05	>0.05	<0.05